Shakeel Amanullah, MD
Critical Care Medicine · Lancaster, PANPI 1629049036
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $643 of the $871 with a category attached, or 73.8%. Intuitive Surgical accounts for 87.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $695 and has fallen 90.4% since, to $67 in 2025.
Across 12 payments — averaging $72.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$764
- AstraZeneca$47
- Insmed, Inc.$32
- Novartis$17
- Breas Medical, Inc.$11
Across 42 payments — averaging $3311.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$139K
What the payments were for
- Travel & lodging$64374%
- Food & beverage$20524%
- Education$233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $764 |
| AstraZeneca | 3 | $47 |
| Insmed, Inc. | 1 | $32 |
| Novartis | 1 | $17 |
| Breas Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$871 in reported general payments places this provider in the 70th percentile of 354 critical care medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 102 | $81,299 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $17,623 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 80 | $16,619 |
| Advair HfaFluticasone Propion/Salmeterol | 30 | $16,485 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 88 | $12,865 |
| Spiriva RespimatTiotropium Bromide | 15 | $10,919 |
| EliquisApixaban | 14 | $7,723 |
| Fluticasone-Salmeterol HfaFluticasone Propion/Salmeterol | 11 | $5,223 |
| Arnuity ElliptaFluticasone Furoate | 18 | $4,868 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 114 | $3,604 |
| Roflumilast | 34 | $2,741 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $2,163 |
| Ventolin HfaAlbuterol Sulfate | 20 | $1,944 |
| Fluticasone Propionate | 133 | $1,614 |
| Ipratropium Bromide | 71 | $1,296 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Lancaster
- Lisa RathmanLancaster$86K
- Jill SchaefferLancaster$4K
- Briana DisilvioPittsburgh$204K
- Meilin YoungPittsburgh$182K
- Robert KruklitisAllentown$148K
- Kees PoldermanPittsburgh$85K
- Pavan ThanguduHarrisburg$78K
- David DibardinoPhiladelphia$63K
- Harold PalevskyPhiladelphia$55K
- Steven KawutPhiladelphia$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.